tuberculosis, drug resistance, randomised clinical trial, pragmatic trial, whole genome sequencing, precision medicine
tuberculosis, antimicrobial resistance, genomics, next generation sequencing, whole genome sequencing, variant interpretation
Mycobacterium tuberculosis, MmpL3, anti-mycobacterial, screening, whole genome sequencing
tuberculosis, drug-resistance, whole genome sequencing, health economics, cost-effectiveness, within-trial analysis, DALY, ICER, INMB, ROI
Tuberculosis, drug-resistant tuberculosis, bedaquiline, novel drug, programmatic, bedaquiline-resistance, bedaquiline phenotypic DST, whole genome sequencing, targeted deep sequencing